CLINICAL_TRIALS
trial_result
· 2023-02-28
Clinical Trial Update: Study of VVN001 Ophthalmic Solution in Dry Eye Disease [Phase 2]
Summary
A Phase 2 clinical trial of VVN001 Ophthalmic Solution for dry eye disease has been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VivaVision Biotech, Inc | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2023-02-28